This website uses cookies to store user session information. By using our website you consent to our terms of use. Read more
I agree

Andres Veske

https://www.etis.ee/CV/Andres_Veske_001/eng
4.07.1965
51 61186
6204403
andres.veske@taltech.ee
http://

Career

Institutions and positions
01.12.2020–...   
Tallinn University of Technology , School of Science, Department of Chemistry and Biotechnology, Senior Lecturer (0,75)
01.01.2017–31.12.2018   
Tallinn University of Technology , School of Science, Department of Chemistry and Biotechnology, Senior Researcher (0,10)
01.01.2017–30.11.2020   
Tallinn University of Technology , School of Science, Department of Chemistry and Biotechnology, Associate Professor (0,75)
2007–01.01.2016   
Tallinn University of Technology , Faculty of Science, Department of Gene Technology, Chair of Molecular Biology, Associate Professor, director of the departement (1,00)
01.01.2007–31.12.2016   
Tallinn University of Technology , Faculty of Science, Department of Gene Technology, Associate Professor (0,50)
2006–31.12.2016   
Tallinn University of Technology , Faculty of Science, Department of Gene Technology, Senior Researcher (0,50)
2005–01.01.2015   
Competence Center for Cancer Research, Project leader (0,50)
2002–2005   
Tallinn University of Technology , Faculty of Science, Department of Gene Technology, Professor extraordinarius (1,00)
01.01.1998–31.12.2002   
Postdoctoral fellowship at the University of Hamburg, Institute of Human Genetics
01.01.1995–31.12.1998   
Ph.D. student at the University of Hamburg, Institute of Human Genetics
01.01.1993–31.12.1995   
Visiting scientists at the Medical University of Lübeck, Institute of Human Genetics, group of molecular genetics
1991–1993   
University of Tartu, Faculty of Medicine, Departement of General and Molecular Pathology, Immunoanalüüsi uurimisgrupp, Researcher (0,50)
 
 
Education
Tallinn Secondary School No 43., graduated in 1983, University of Tartu, Faculty of Biology and Geography, graduated as cell biologist in 1991
 
 
R&D related managerial and administrative work
2020−...   
Euroopa Horisondi tervise klastri varikomitee ning programmikomitee delegaadi nõuandereühma liige
2017−...   
Molecular Psychiatry and Neurochemistry reviwer
2007−...   
Member of the board of the Estonian Society of Human Genetics
2002−...   
Member of the Estonian Society of Human Genetics
2018−2020   
TUT, member of the board of Institute of Chemistry and Biotechnology
2014−2016   
Loomkatsette loataotluse komisjoni liige (Maaeluministeerium)
2009−2016   
Vice president of the Estonian Society of Human Genetics
2008−2010   
Member of the board of TUT
2007−2016   
director of the department of gene technology
2007−2015   
TUT, member of the board of Institue of Clinical Medicine
 
 
Creative work
Editor of the Estonian TEA encyclopedia.
 
 
Additional information
Viimasel viiel aastal olen pidanud loengukursuseid geneetikas (YTM0060) ja molekulaardiagnostikas (YTD0011). Lisaks loengud genoomika ja proteoomika (YTP0070 genoomika osa), bioloogia ajalugu (YTM0070), rakubioloogia II (YTM8022) ja bioloogilise ohutuse loengute raames (YTG0140). Olen kureerinnud õppeaineid molekulaarne rakubioloogia (YTG9011), labratooriumi praktika (YTX0030), magistripraktika (YTX0040) ja laboratoorne eripraktika (YTX0050). Viimasel kahel aastal (alates 2018) olen pidanud loenguid ka Tallinna Ülikoolis, milleks on Organismide ontogenees ja Kloonimine ja ekspressioon prokarüootides. Lisaks pean loengusarja Molekulaar- ja rakubioloogia GAG-i gümnasistidele. Olen lugenud Molekulaarse kloneerimise, Evolutsiooni ja Organismide ontogeneesi loenguid magistrantidele Tallinna Ülikoolis aastatel 2017-2020.

Qualifications

Academic degrees
Andres Veske, Doctor's Degree, 1998, (sup) Andreas Gal, Molecular genetic analysis of candidate genes for the retinal dystrophy of Swedish Briard/Briard-Beagle dogs (Molecular genetic analysis of candidate genes for the retinal dystrophy of Swedish Briard/Briard-Beagle dogs), Hamburg University.
 
 
Fields of research
ETIS RESEARCH FIELD: 1. Biosciences and Environment; 1.3. Genetics
 
 

Completed projects

Dissertations under supervision

Supervised dissertations

Publications

Category
Year
Publication
 
1.2.
2019
Gаbovich, B. E.; Veske, A.; Dаi, F.; Kolesnikov, Yu. A. (2019). Association of genetic polymorphism of guanosintriphosphate of cyclohydrolases and catechol-O-methyltransferase with the frequency of the appearance of chronic pain after surgery. Messenger of Anesthesiology and Resuscitation, 16 (5), 5−11. DOI: 10.21292/2078-5658-2019-16-5-5-11.
1.1.
2015
Laht, Piret; Tammaru, Epp; Otsus, Marrja; Rohtla, Johan; Tiismus, Liivi; Veske, Andres (2015). Plexin-B3 suppresses excitatory and promotes inhibitory synapse formation in rat hippocampal neurons. Experimental Cell Research, 335 (2), 269−278. DOI: 10.1016/j.yexcr.2015.05.007.
1.1.
2014
Laht, Piret; oTSUS, Maarja; Remm, Jaanus; Veske, Andres (2014). B-plexins control microtubule dynamics and dendrite morphology of hippocampal neurons. Experimental Cell Research, 326 (1), 174−184.
1.1.
2013
Kolesnikov, Yuri; Gabovits, Boris; Levin, Ariel; Veske, Andres; Qin, Li; Dai, Feng; Belfer, Inna (2013). Chronic pain after lower abdominal surgery: do catechol-O-methyl transferase/opioid receptor μ-1 polymorphisms contribute? Molecular Pain, 9, 1−7.10.1186/1744-8069-9-19.
5.1.
2013
Laht, Piret; Pill, Kaie; Haller, Elina; Remm, Jaanus; Veske, Andres (2013). B-plexins control microtubule dynamica and dendritic morphology in co-operation with end-binding proteins. EMBO workshop Semaphorin function & mechanism of action.
6.3.
2013
Veske, Andres (2013). Eesti autori geneetikaõpik. Horisont, 2, 59.
1.1.
2012
Laht, Piret; Pill, Kaie; Haller, Elina; Veske, Andres (2012). Plexin-B3 interacts with EB-family proteins through a conserved motif. Biochimica et Biophysica Acta (BBA) - General Subjects, 1820 (7), 888−893. DOI: 10.1016/j.bbagen.2012.02.007.
5.1.
2012
Laht, Piret; Pill, Kaie; Haller, Elina; Veske, Andres (2012). Plexin-B3 interacts with EB-family proteins through a conserved motif. EMBO Conference „Microtubules: Structure, Regulation and Functions“, 23-26 mai 2012.
1.1.
2011
Kolesnikov, Yuri; Gabovits, Boris; Levin, Ariel; Voiko, Edward; Veske, Andres (2011). Combined Catechol-O-Methyltransferase and {micro}-Opioid Receptor Gene Polymorphisms Affect Morphine Postoperative Analgesia and Central Side Effects. Anesthesia and Analgesia, 112 (2), 448−453.
6.3.
2011
Veske, Andres; Kalling, Ken (2011). Parema inimrassi suunas. Horisont, 2, 10−17.
1.1.
2008
Tiismus, Liivi; Laht, Piret; Otsus, Maarja; Veske, Andres (2008). Identification and characterization of mouse plexin B3 promoter. Biochemical and Biophysical Research Communications, 375, 11−15.
3.1.
2008
Tiismus, Liivi; Laht, Piret; Otsus, Maarja; Veske, Andres (2008). Chracterization of the rodent PLXNB3 gene and its minimal promoter. Axon guidance, synaptogenesis and neural plasticity, Cold Spring Harbor 2008, september 10-14. Cold Spring Harbor Lab Press, 243−243.
5.1.
2008
Kurvinen, E.; Nueganen, K.; Viigimaa, M.; Veske, A.; Aasvee, K. (2008). Matrix metalloproteinase-9 polymorphism in relation to cardiovascular disease complications in patients of type 2 diabetes mellitus. European Journal of Human Genetics, 16(Suppl 2): European Human Genetics Conference 2008, Barcelona, Spain, May 31 - June 3, 2008. , 326.
6.1.
2008
Veske, Andres (2008). TEA entsüklopeedia biokeemia ja mikrobioloogia toimkonna juht. TEA Kirjastus.
1.1.
2007
Rujescu, D.; Meisenzahl, E.; Krejcova, S.; Giegling, I.; Zetsche, T.; Reiser, M.; Born, C.; Möller, H.; Veske, A.; Gal, A.; Finckh, U. (2007). Plexin B3 is genetically associated with verbal performance and white matter volume in human brain. Molecular Psychiatry, 12, 190−194.
1.1.
2005
Hartwig, C.; Veske, A.; Krejcova, S.; Rosenberger, G.; Finckh, U. (2005). Plexin B3 promotes neurite outgrowth, interacts homophilically, and interacts with Rin. BMC Neuroscience, 6, 53.
5.1.
2004
Finckh, U; Veske, S; Hartwig, C; Rujescu, D; Meisenzahl, EM; Giegling, A; Veske, A (2004). Plexin B3 promotes neurite outgrowth and may be genetically associated with verbal performance and white matter volume in human brain. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 130B. 25−26. (1).
5.2.
2004
Veske, A (2004). Ajumahu ja üldintelligentsuse seosed genotüübiga.
1.1.
2002
Michelson, P.; Hartwig, C.; Schachner, M.; Gal, A.; Veske, A.; Finckh, U. (2002). Missense mutations in the extracellular domain of the human neural cell adhesion molecule L1 reduce neurite outgrowth of murine cerebellar neurons. Human Mutation, 20 (6), 481−482.
5.1.
2002
Michelson, P; Hartwig, C; Schachner, M; Gal, A; Veske, A; Finckh, U (2002). A cell culture-based model for neurodevelopmental disorder: Reduced neurite outgrowth due to mutations in the human neural cell adhesion molecule L1. AMERICAN JOURNAL OF MEDICAL GENETICS, 114. (7).
1.1.
2000
Finckh, U.; Schroder, J.; Ressler, B.; Veske, A.; Gal, A. (2000). Spectrum and detection rate of L1CAM mutations in isolated and familial cases with clinically suspected L1-disease. American Journal of Medical Genetics, 92, 40−46.
5.1.
2000
Finckh, U; Veske, A; Marksteiner, J; Gal, A (2000). Prion protein, presenilin, and APP mutations in early-onset dementia. AMERICAN JOURNAL OF MEDICAL GENETICS, 96. 565−565. (4).
5.1.
2000
Michelson, P.; Veske, A; Finckh, U (2000). In vitro expression of human L1CAM missense mutations. American Journal of Medical Genetics, 96. 565−565. (4).
1.1.
1999
Veske, A.; Nilsson, S.E.G.; Narfström, K.; Gal, A. (1999). Retinal dystrophy of Swedish Briard/Briard-Beagle dogs is due to a 4-bp deletion in RPE 65. Genomics, 57, 57-61.
5.1.
1999
Scott, HS; Berry, A; Korostishevsky, M; Talior, I; Barras, C; Gehrig, C; Younus, F; Veske, A; Mohyuddin, A; Mehdi, SQ; Gal, A; Kudoh, J; Shimizu, N; Bonne-Tamir, B; Antonarakis, SE (1999). The autosomal recessive non-syndromic deafness loci, DFNB8 and DFNB10 on human chromosome 21q22.3, are distinct loci. CYTOGENETICS AND CELL GENETICS, 86. 19−19. (1).
5.1.
1999
Scott, HS; Berry, A; Korostishevsky, M; Talior, I; Barras, C; Gehrig, C; Younus, F; Veske, A; Mohyuddin, A; Mehdi, SQ; Gal, A; Kudoh, J; Shimizu, N; Bonne-Tamir, B; Antonarakis, SE (1999). The autosomal recessive non-syndromic deafness loci, DFNB8 and DFNB10 on human chromosome 21q22.3, are distinct loci. AMERICAN JOURNAL OF HUMAN GENETICS, 65. A445−A445. (4).
1.1.
1998
Veske, A.; Nilsson, S.E.G.; Narfström, K.; Gal, A. (1998). Organization of the canine gene encoding the E isoform of retinal guanylate cyclase (cGC-E) and exclusion of its involvement in the inherited retinal dystrophy of the Swedish Briard and Briard/Beagle dogs. Biochimica et Biophysica Acta, 1372, 69−77.
5.1.
1998
Katic, M; Veske, A; Finckh, U (1998). Comparative measurement of allelic dopamine D2 receptor gene (DRD2) expression in cultured lymphocytes from blood samples. AMERICAN JOURNAL OF MEDICAL GENETICS, 81. 497−497. (6).
1.1.
1997
Veske, A; Narfström, K; Finckh, U; Sargan, D; Nilsson, SE; Gal, A (1997). Isolation of canine retinal arrestin cDNA and exclusion of three candidate genes for Swedish Briard retinal dystrophy. Current Eye Research, 270−274.
1.1.
1997
Veske, A; Nilsson, GE; Gal, A (1997). Mucrosatellite (TTCC)n polymorphism in intrn 6 of the canine rod photoreceptor cGMP-gated cation channel alpha-subunit gene. Animal Genetics, 374−375.
1.1.
1997
Veske, A; Nilsson, GE; Gal, A (1997). Microsatellite (CA)n polymorphism in intron 2 of the canine rod photoreceptor cGMP-phosphodiesterase alpha-subunit gene. Animal Genetics, 5, 380.
1.1.
1997
Veske, A; Nilsson, SE; Gal, A (1997). Characterization of canine rod photoreceptor cGMP-gated cation channel alpha-subunit gene and exclusion of its involvement in the hereditary retinal dystrophy of Swedish Briards. Gene, 202, 115−119.
1.1.
1996
Veske, A; Oehlmann, R; Younus, F; Mohyuddin, A; Mueller-Myhsok, B, Mehdi, SQ, Gal, A (1996). Autosomal recessive non-syndromic deafness locus (DFNB8) maps on chromosome 21q22 in a large consanguineous kindred from Pakistan. Human Molecular Genetics, 1, 165−168.
1.1.
1996
Gu, S; Orth, U; Veske, A; Enders, H; Klunder, K; Schlosser, M, Engel, W; Schwinger, E; Gal, A (1996). Five novel mutations in the L1CAM gene in families with X linked hydrocephalus. Journal of Medical Genetics, 103−106.
1.1.
1996
Caballero, M; Veske, A; Rodrigues, JJ; Lugo, N; Schroeder, B; Hesse, L; Gal, A (1996). Two novel mutations in the Norrie disease gene associated with the classical ocular phenotype. Ophthalmic Genetics, 187−191.
5.2.
1992
Juronen, E; Sikut, R; Veske, A; Mikelsaar, AV (1992). Development of monoclonal antibodies based ELISA methods for thyroxine and thyrotropin iin human sera.
24.10.2021

Andres Veske

https://www.etis.ee/CV/Andres_Veske_001/est
4.07.1965
51 61186
6204403
andres.veske@taltech.ee

Teenistuskäik

Töökohad ja ametid
01.12.2020–...   
Tallinna Tehnikaülikool, Loodusteaduskond, Keemia ja biotehnoloogia instituut, Vanemlektor (0,75)
01.01.2017–31.12.2018   
Tallinna Tehnikaülikool, Loodusteaduskond, Keemia ja biotehnoloogia instituut, Vanemteadur (0,10)
01.01.2017–30.11.2020   
Tallinna Tehnikaülikool, Loodusteaduskond, Keemia ja biotehnoloogia instituut, Dotsent (0,75)
2007–01.01.2016   
Tallinna Tehnikaülikool, Matemaatika-loodusteaduskond, Geenitehnoloogia instituut, Molekulaarbioloogia õppetool, dotsent, direktor (1,00)
01.01.2007–31.12.2016   
Tallinna Tehnikaülikool, Matemaatika-loodusteaduskond, Geenitehnoloogia instituut, Dotsent (0,50)
2006–31.12.2016   
Tallinna Tehnikaülikool, Matemaatika-loodusteaduskond, Geenitehnoloogia instituut, Vanemteadur (0,50)
2005–01.01.2015   
Vähiuuringute Tehnoloogia Arenduskeskus AS, Projektijuht (0,50)
2002–2005   
Tallinna Tehnikaülikool, Matemaatika-loodusteaduskond, Geenitehnoloogia instituut, Erakorraline professor (1,00)
01.01.1998–31.12.2002   
Hamburgi Ülikool, Inimesegeneetika Instituut, teadur
01.01.1995–31.12.1998   
Hamburgi Ülikool, Inimesegeneetika Instituut, doktorant
01.01.1993–31.12.1995   
Lübecki Meditsiiniülikooli Inimesegeneetika Instituudi molekulaargeneetika grupi külalisteadlane
1991–1993   
Tartu Ülikool, Arstiteaduskond, Üld- ja molekulaarpatoloogia instituut, Immunoanalüüsi uurimisgrupp, Teadur (0,50)
 
 
Haridustee
Tallinna 43.Keskkool, 1983. a. Tartu Ülikool, Bioloogia-geograafiateaduskond, rakubioloog 1991. a.
 
 
Teadusorganisatsiooniline ja -administratiivne tegevus
2020−...   
Euroopa Horisondi tervise klastri varikomitee ning programmikomitee delegaadi nõuandereühma liige
2017−...   
Molecular Psychiatry ja Neurochemistry retsensent
2007−...   
Eesti Inimesegeneetika ühingu juhatuse liige
2002−...   
Eesti Inimesegeneetika Ühingu liige
2018−2020   
TTÜ Keemia ja biotehnoloogia instituudi nõukogu liige
2014−2016   
Loomkatsette loataotluse komisjoni liige (Maaeluministeerium)
2009−2016   
Eesti inimesegeneetika ühingu asepresident
2008−2010   
TTÜ nõukogu liige
2007−2016   
geenitehnoloogia instituud direktor
2007−2015   
TTÜ, Kliinilise Meditsiini Instituudi nõukogu liige
 
 
Loometöö
TEA entsüklopeedia toimetaja.
 
 
Lisainfo
Viimasel viiel aastal olen pidanud loengukursuseid geneetikas (YTM0060) ja molekulaardiagnostikas (YTD0011). Lisaks loengud genoomika ja proteoomika (YTP0070 genoomika osa), bioloogia ajalugu (YTM0070), rakubioloogia II (YTM8022) ja bioloogilise ohutuse loengute raames (YTG0140). Olen kureerinnud õppeaineid molekulaarne rakubioloogia (YTG9011), labratooriumi praktika (YTX0030), magistripraktika (YTX0040) ja laboratoorne eripraktika (YTX0050). Viimasel kahel aastal (alates 2018) olen pidanud loenguid ka Tallinna Ülikoolis, milleks on Organismide ontogenees ja Kloonimine ja ekspressioon prokarüootides. Lisaks pean loengusarja Molekulaar- ja rakubioloogia GAG-i gümnasistidele. Olen lugenud Molekulaarse kloneerimise, Evolutsiooni ja Organismide ontogeneesi loenguid magistrantidele Tallinna Ülikoolis aastatel 2017-2020.

Kvalifikatsioon

Teaduskraadid
Andres Veske, Doctor's Degree, 1998, (sup) Andreas Gal, Molecular genetic analysis of candidate genes for the retinal dystrophy of Swedish Briard/Briard-Beagle dogs (Molecular genetic analysis of candidate genes for the retinal dystrophy of Swedish Briard/Briard-Beagle dogs), Hamburg University.
 
 
Teadustöö põhisuunad
ETIS VALDKOND: 1. Bio- ja keskkonnateadused; 1.3. Geneetika

Lõppenud projektid

Juhendamisel väitekirjad

Juhendatud väitekirjad

Publikatsioonid

Klass
Aasta
Publikatsioon
 
1.2.
2019
Gаbovich, B. E.; Veske, A.; Dаi, F.; Kolesnikov, Yu. A. (2019). Association of genetic polymorphism of guanosintriphosphate of cyclohydrolases and catechol-O-methyltransferase with the frequency of the appearance of chronic pain after surgery. Messenger of Anesthesiology and Resuscitation, 16 (5), 5−11. DOI: 10.21292/2078-5658-2019-16-5-5-11.
1.1.
2015
Laht, Piret; Tammaru, Epp; Otsus, Marrja; Rohtla, Johan; Tiismus, Liivi; Veske, Andres (2015). Plexin-B3 suppresses excitatory and promotes inhibitory synapse formation in rat hippocampal neurons. Experimental Cell Research, 335 (2), 269−278. DOI: 10.1016/j.yexcr.2015.05.007.
1.1.
2014
Laht, Piret; oTSUS, Maarja; Remm, Jaanus; Veske, Andres (2014). B-plexins control microtubule dynamics and dendrite morphology of hippocampal neurons. Experimental Cell Research, 326 (1), 174−184.
1.1.
2013
Kolesnikov, Yuri; Gabovits, Boris; Levin, Ariel; Veske, Andres; Qin, Li; Dai, Feng; Belfer, Inna (2013). Chronic pain after lower abdominal surgery: do catechol-O-methyl transferase/opioid receptor μ-1 polymorphisms contribute? Molecular Pain, 9, 1−7.10.1186/1744-8069-9-19.
5.1.
2013
Laht, Piret; Pill, Kaie; Haller, Elina; Remm, Jaanus; Veske, Andres (2013). B-plexins control microtubule dynamica and dendritic morphology in co-operation with end-binding proteins. EMBO workshop Semaphorin function & mechanism of action.
6.3.
2013
Veske, Andres (2013). Eesti autori geneetikaõpik. Horisont, 2, 59.
1.1.
2012
Laht, Piret; Pill, Kaie; Haller, Elina; Veske, Andres (2012). Plexin-B3 interacts with EB-family proteins through a conserved motif. Biochimica et Biophysica Acta (BBA) - General Subjects, 1820 (7), 888−893. DOI: 10.1016/j.bbagen.2012.02.007.
5.1.
2012
Laht, Piret; Pill, Kaie; Haller, Elina; Veske, Andres (2012). Plexin-B3 interacts with EB-family proteins through a conserved motif. EMBO Conference „Microtubules: Structure, Regulation and Functions“, 23-26 mai 2012.
1.1.
2011
Kolesnikov, Yuri; Gabovits, Boris; Levin, Ariel; Voiko, Edward; Veske, Andres (2011). Combined Catechol-O-Methyltransferase and {micro}-Opioid Receptor Gene Polymorphisms Affect Morphine Postoperative Analgesia and Central Side Effects. Anesthesia and Analgesia, 112 (2), 448−453.
6.3.
2011
Veske, Andres; Kalling, Ken (2011). Parema inimrassi suunas. Horisont, 2, 10−17.
1.1.
2008
Tiismus, Liivi; Laht, Piret; Otsus, Maarja; Veske, Andres (2008). Identification and characterization of mouse plexin B3 promoter. Biochemical and Biophysical Research Communications, 375, 11−15.
3.1.
2008
Tiismus, Liivi; Laht, Piret; Otsus, Maarja; Veske, Andres (2008). Chracterization of the rodent PLXNB3 gene and its minimal promoter. Axon guidance, synaptogenesis and neural plasticity, Cold Spring Harbor 2008, september 10-14. Cold Spring Harbor Lab Press, 243−243.
5.1.
2008
Kurvinen, E.; Nueganen, K.; Viigimaa, M.; Veske, A.; Aasvee, K. (2008). Matrix metalloproteinase-9 polymorphism in relation to cardiovascular disease complications in patients of type 2 diabetes mellitus. European Journal of Human Genetics, 16(Suppl 2): European Human Genetics Conference 2008, Barcelona, Spain, May 31 - June 3, 2008. , 326.
6.1.
2008
Veske, Andres (2008). TEA entsüklopeedia biokeemia ja mikrobioloogia toimkonna juht. TEA Kirjastus.
1.1.
2007
Rujescu, D.; Meisenzahl, E.; Krejcova, S.; Giegling, I.; Zetsche, T.; Reiser, M.; Born, C.; Möller, H.; Veske, A.; Gal, A.; Finckh, U. (2007). Plexin B3 is genetically associated with verbal performance and white matter volume in human brain. Molecular Psychiatry, 12, 190−194.
1.1.
2005
Hartwig, C.; Veske, A.; Krejcova, S.; Rosenberger, G.; Finckh, U. (2005). Plexin B3 promotes neurite outgrowth, interacts homophilically, and interacts with Rin. BMC Neuroscience, 6, 53.
5.1.
2004
Finckh, U; Veske, S; Hartwig, C; Rujescu, D; Meisenzahl, EM; Giegling, A; Veske, A (2004). Plexin B3 promotes neurite outgrowth and may be genetically associated with verbal performance and white matter volume in human brain. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 130B. 25−26. (1).
5.2.
2004
Veske, A (2004). Ajumahu ja üldintelligentsuse seosed genotüübiga.
1.1.
2002
Michelson, P.; Hartwig, C.; Schachner, M.; Gal, A.; Veske, A.; Finckh, U. (2002). Missense mutations in the extracellular domain of the human neural cell adhesion molecule L1 reduce neurite outgrowth of murine cerebellar neurons. Human Mutation, 20 (6), 481−482.
5.1.
2002
Michelson, P; Hartwig, C; Schachner, M; Gal, A; Veske, A; Finckh, U (2002). A cell culture-based model for neurodevelopmental disorder: Reduced neurite outgrowth due to mutations in the human neural cell adhesion molecule L1. AMERICAN JOURNAL OF MEDICAL GENETICS, 114. (7).
1.1.
2000
Finckh, U.; Schroder, J.; Ressler, B.; Veske, A.; Gal, A. (2000). Spectrum and detection rate of L1CAM mutations in isolated and familial cases with clinically suspected L1-disease. American Journal of Medical Genetics, 92, 40−46.
5.1.
2000
Finckh, U; Veske, A; Marksteiner, J; Gal, A (2000). Prion protein, presenilin, and APP mutations in early-onset dementia. AMERICAN JOURNAL OF MEDICAL GENETICS, 96. 565−565. (4).
5.1.
2000
Michelson, P.; Veske, A; Finckh, U (2000). In vitro expression of human L1CAM missense mutations. American Journal of Medical Genetics, 96. 565−565. (4).
1.1.
1999
Veske, A.; Nilsson, S.E.G.; Narfström, K.; Gal, A. (1999). Retinal dystrophy of Swedish Briard/Briard-Beagle dogs is due to a 4-bp deletion in RPE 65. Genomics, 57, 57-61.
5.1.
1999
Scott, HS; Berry, A; Korostishevsky, M; Talior, I; Barras, C; Gehrig, C; Younus, F; Veske, A; Mohyuddin, A; Mehdi, SQ; Gal, A; Kudoh, J; Shimizu, N; Bonne-Tamir, B; Antonarakis, SE (1999). The autosomal recessive non-syndromic deafness loci, DFNB8 and DFNB10 on human chromosome 21q22.3, are distinct loci. CYTOGENETICS AND CELL GENETICS, 86. 19−19. (1).
5.1.
1999
Scott, HS; Berry, A; Korostishevsky, M; Talior, I; Barras, C; Gehrig, C; Younus, F; Veske, A; Mohyuddin, A; Mehdi, SQ; Gal, A; Kudoh, J; Shimizu, N; Bonne-Tamir, B; Antonarakis, SE (1999). The autosomal recessive non-syndromic deafness loci, DFNB8 and DFNB10 on human chromosome 21q22.3, are distinct loci. AMERICAN JOURNAL OF HUMAN GENETICS, 65. A445−A445. (4).
1.1.
1998
Veske, A.; Nilsson, S.E.G.; Narfström, K.; Gal, A. (1998). Organization of the canine gene encoding the E isoform of retinal guanylate cyclase (cGC-E) and exclusion of its involvement in the inherited retinal dystrophy of the Swedish Briard and Briard/Beagle dogs. Biochimica et Biophysica Acta, 1372, 69−77.
5.1.
1998
Katic, M; Veske, A; Finckh, U (1998). Comparative measurement of allelic dopamine D2 receptor gene (DRD2) expression in cultured lymphocytes from blood samples. AMERICAN JOURNAL OF MEDICAL GENETICS, 81. 497−497. (6).
1.1.
1997
Veske, A; Narfström, K; Finckh, U; Sargan, D; Nilsson, SE; Gal, A (1997). Isolation of canine retinal arrestin cDNA and exclusion of three candidate genes for Swedish Briard retinal dystrophy. Current Eye Research, 270−274.
1.1.
1997
Veske, A; Nilsson, GE; Gal, A (1997). Mucrosatellite (TTCC)n polymorphism in intrn 6 of the canine rod photoreceptor cGMP-gated cation channel alpha-subunit gene. Animal Genetics, 374−375.
1.1.
1997
Veske, A; Nilsson, GE; Gal, A (1997). Microsatellite (CA)n polymorphism in intron 2 of the canine rod photoreceptor cGMP-phosphodiesterase alpha-subunit gene. Animal Genetics, 5, 380.
1.1.
1997
Veske, A; Nilsson, SE; Gal, A (1997). Characterization of canine rod photoreceptor cGMP-gated cation channel alpha-subunit gene and exclusion of its involvement in the hereditary retinal dystrophy of Swedish Briards. Gene, 202, 115−119.
1.1.
1996
Veske, A; Oehlmann, R; Younus, F; Mohyuddin, A; Mueller-Myhsok, B, Mehdi, SQ, Gal, A (1996). Autosomal recessive non-syndromic deafness locus (DFNB8) maps on chromosome 21q22 in a large consanguineous kindred from Pakistan. Human Molecular Genetics, 1, 165−168.
1.1.
1996
Gu, S; Orth, U; Veske, A; Enders, H; Klunder, K; Schlosser, M, Engel, W; Schwinger, E; Gal, A (1996). Five novel mutations in the L1CAM gene in families with X linked hydrocephalus. Journal of Medical Genetics, 103−106.
1.1.
1996
Caballero, M; Veske, A; Rodrigues, JJ; Lugo, N; Schroeder, B; Hesse, L; Gal, A (1996). Two novel mutations in the Norrie disease gene associated with the classical ocular phenotype. Ophthalmic Genetics, 187−191.
5.2.
1992
Juronen, E; Sikut, R; Veske, A; Mikelsaar, AV (1992). Development of monoclonal antibodies based ELISA methods for thyroxine and thyrotropin iin human sera.
24.10.2021